Ad
Thursday, 21 June 2018
Israel's UroGen to start mid-stage bladder cancer trial
RAANANA, Israel (Reuters) - Israel's UroGen Pharma plans to begin a mid-stage trial of its treatment for bladder cancer patients in August, after positive interim results last month from an advanced trial of a treatment for upper urinary tract cancer.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment